| 47267-0 |
Adenosine monophosphate.cyclic^6th specimen post XXX challenge |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine monophosphate.cyclic [Moles/volume] in Urine --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHAL |
|
47267-0 |
|
|
|
|
Observation |
|
|
|
0 |
cAMP sp6 p chal Ur-sCnc |
|
|
|
N |
|
Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; After; AMP; ANED; cAMP; CHEMISTRY.CHALLENGE TESTING; CMP; Level; Medication stress; p chal; Phosphaden; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp6; sp6 p chal; Spec; Substance concentration; UA; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 47268-8 |
Adenosine monophosphate.cyclic/Creatinine^6th specimen post XXX challenge |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/mg creatinine |
8.5 nmol/mg creat |
|
|
|
|
|
CHAL |
|
47268-8 |
|
|
|
|
Observation |
|
|
|
0 |
cAMP/Creat sp6 p chal Ur-Rto |
|
|
|
N |
|
Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; After; AMP; ANED; cAMP; CHEMISTRY.CHALLENGE TESTING; CMP; CR; Crea; Creat; Medication stress; p chal; Phosphaden; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; sp6; sp6 p chal; Spec; UA; UCr; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/mg{creat} |
|
|
|
0 |
| 47269-6 |
Adenosine monophosphate.cyclic/Creatinine^2nd specimen post XXX challenge |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2nd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/mg creatinine |
|
|
|
|
|
|
CHAL |
|
47269-6 |
|
|
|
|
Observation |
|
|
|
0 |
cAMP/Creat sp2 p chal Ur-Rto |
|
|
|
N |
|
Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; After; AMP; ANED; cAMP; CHEMISTRY.CHALLENGE TESTING; CMP; Convalescent; CR; Crea; Creat; Medication stress; p chal; Phosphaden; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Second; sp2; sp2 p chal; Spec; UA; UCr; UR; Urn |
2.73 |
2.19 |
|
|
|
|
|
|
|
nmol/mg{creat} |
|
|
|
0 |
| 4727-4 |
HLA-A28 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-A28 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4727-4 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A28 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47270-4 |
Adenosine monophosphate.cyclic/Creatinine^3rd specimen post XXX challenge |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --3rd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/mg creatinine |
|
|
|
|
|
|
CHAL |
|
47270-4 |
|
|
|
|
Observation |
|
|
|
0 |
cAMP/Creat sp3 p chal Ur-Rto |
|
|
|
N |
|
Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; After; AMP; ANED; cAMP; CHEMISTRY.CHALLENGE TESTING; CMP; CR; Crea; Creat; Medication stress; p chal; Phosphaden; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; sp3; sp3 p chal; Spec; UA; UCr; UR; Urn |
2.73 |
2.19 |
|
|
|
|
|
|
|
nmol/mg{creat} |
|
|
|
0 |
| 47271-2 |
Adenosine monophosphate.cyclic/Creatinine^4th specimen post XXX challenge |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/mg creatinine |
|
|
|
|
|
|
CHAL |
|
47271-2 |
|
|
|
|
Observation |
|
|
|
0 |
cAMP/Creat sp4 p chal Ur-Rto |
|
|
|
N |
|
Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; After; AMP; ANED; cAMP; CHEMISTRY.CHALLENGE TESTING; CMP; CR; Crea; Creat; Medication stress; p chal; Phosphaden; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; sp4; sp4 p chal; Spec; UA; UCr; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/mg{creat} |
|
|
|
0 |
| 47272-0 |
Adenosine monophosphate.cyclic/Creatinine^5th specimen post XXX challenge |
Ratio |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/mg creatinine |
|
|
|
|
|
|
CHAL |
|
47272-0 |
|
|
|
|
Observation |
|
|
|
0 |
cAMP/Creat sp5 p chal Ur-Rto |
|
|
|
N |
|
Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; After; AMP; ANED; cAMP; CHEMISTRY.CHALLENGE TESTING; CMP; CR; Crea; Creat; Medication stress; p chal; Phosphaden; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; sp5; sp5 p chal; Spec; UA; UCr; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/mg{creat} |
|
|
|
0 |
| 47273-8 |
Creatinine^5th specimen post XXX challenge |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Creatinine [Mass/volume] in Urine --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
g/L; mcg/mL; mg/dL; mg/mL |
17.0 mg/dL |
|
|
|
|
|
CHAL |
|
47273-8 |
|
|
|
|
Observation |
|
|
|
0 |
Creat sp5 p chal Ur-mCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp5; sp5 p chal; Spec; UA; UCr; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 47274-6 |
S100 calcium binding protein B |
MCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
S100 calcium binding protein B [Mass/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
ug/L |
0.38 ug/L |
|
|
|
|
|
CHEM |
|
47274-6 |
|
|
|
|
Both |
|
|
|
0 |
S100 Ca binding protein B CSF-mCnc |
|
|
|
N |
|
Bind; Ca; Cal; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Neuro; Neurology; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; S100 Ca binding protein B; S-100B; S-100-beta; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.7 |
2.19 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 47275-3 |
S100 calcium binding protein B |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
S100 calcium binding protein B [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/L |
0.09 ug/L |
|
|
|
|
|
CHEM |
|
47275-3 |
|
|
|
|
Both |
|
|
|
0 |
S100 Ca binding protein B Ser-mCnc |
|
|
|
N |
|
Bind; Ca; Cal; Chemistry; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; S100 Ca binding protein B; S-100B; S-100-beta; Serum; SR |
2.73 |
2.19 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 47276-1 |
Complement Sc5b-9 Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Complement Sc5b-9 Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
47276-1 |
|
|
|
|
Both |
|
|
|
0 |
SC5b9 Ab SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Comp; Complement SC5 B-9; Complement soluble C5b-9; Complmt; HEMATOLOGY/CELL COUNTS; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; SC5b9; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Terminal complement complex; TTC |
2.56 |
2.19 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47277-9 |
Observation |
DistWidth |
RBC^BldCo |
Pt |
Qn |
|
|
ACTIVE |
Erythrocyte [DistWidth] in Red Blood Cells from Cord blood |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
SD of red cell size distribution/MCV |
|
|
|
HEM/BC |
|
47277-9 |
|
|
|
|
Observation |
|
|
|
0 |
RDW RBC BldCo |
|
|
|
N |
|
Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.79 |
2.19 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
| 47278-7 |
Hemoglobin |
EntMass |
RBC^BldCo |
Pt |
Qn |
|
|
ACTIVE |
MCH [Entitic mass] in Cord blood |
|
NAM |
DefinitionDescription |
|
|
pg |
|
|
Hgb (g/L)/RBC(x10^12/L) |
|
|
|
HEM/BC |
|
47278-7 |
|
|
|
|
Observation |
|
|
|
0 |
MCH RBC BldCo Qn |
|
|
|
N |
|
Entitic mass; Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.79 |
2.19 |
|
|
|
|
|
|
|
pg |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: Precoordination of the component with Property: mean concentration; the decision was to post coordinate and separate component and property; Previous Releases: Changed Short Name from 'Erythrocyte mean corpuscular hemoglobin' to 'MCH' for succinctness. |
0 |
| 47279-5 |
Hemoglobin |
EntMCnc |
RBC^BldCo |
Pt |
Qn |
|
|
ACTIVE |
MCHC [Entitic Mass/volume] in Red Blood Cells from Cord blood |
|
NAM |
DefinitionDescription |
|
|
g/L |
|
|
Hgb (g/L)/HCT |
|
|
|
HEM/BC |
|
47279-5 |
|
|
|
|
Observation |
|
|
|
0 |
MCHC RBC BldCo-EntMCnc |
|
|
|
N |
|
Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.79 |
2.19 |
|
|
|
|
|
|
|
g/L |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: Precoordination of the component with Property: mean concentration; the decision was to post coordinate and separate component and property; Previous Releases: Changed Short name 'Erythrocyte mean corpuscular hemoglobin concentration' to 'MCHC' for succinctness. |
0 |
| 4728-2 |
HLA-A29(19) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-A29(19) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4728-2 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A29(19) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47280-3 |
Erythrocytes |
NCnc |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Erythrocytes [#/volume] in Cord blood |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
47280-3 |
|
|
|
|
Both |
|
|
|
0 |
RBC # BldCo |
|
|
|
N |
|
#; ABS; absolute; absolutes; Blood - (umbilical) cord; Cnt; Cord (umbilical) blood; Cord bld; Cord blood; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells |
2.7 |
2.19 |
|
|
|
|
|
|
|
10*9/uL |
|
|
|
0 |
| 47281-1 |
Leukocytes |
NCnc |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Leukocytes [#/volume] in Cord blood |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
47281-1 |
|
|
|
|
Both |
|
|
|
0 |
WBC # BldCo |
|
|
|
N |
|
#; ABS; absolute; absolutes; Blood - (umbilical) cord; Cnt; Cord (umbilical) blood; Cord bld; Cord blood; Count; Count/volume; CT; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.7 |
2.19 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
| 47282-9 |
Observation |
EntMeanVol |
RBC^BldCo |
Pt |
Qn |
|
|
ACTIVE |
MCV [Entitic mean volume] in Cord blood |
|
NAM |
DefinitionDescription |
|
|
fL |
|
|
HCTx1000/RBC (x10^12/L) |
|
|
|
HEM/BC |
|
47282-9 |
|
|
|
|
Both |
|
|
|
0 |
BldCo |
|
|
|
N |
|
Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.79 |
2.19 |
|
|
|
|
|
|
|
fL |
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; Previous Releases: Changed Short Name from 'Erythrocyte mean corpuscular volume' to 'MCV' for succinctness. |
0 |
| 47283-7 |
Platelet |
EntMeanVol |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Platelet [Entitic mean volume] in Cord blood |
|
NAM |
DefinitionDescription |
|
|
fL |
|
|
|
|
|
|
HEM/BC |
|
47283-7 |
|
|
|
|
Both |
|
|
|
0 |
PMV BldCo |
|
|
|
N |
|
Blood - (umbilical) cord; Cord (umbilical) blood; Cord bld; Cord blood; HEMATOLOGY/CELL COUNTS; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes |
2.79 |
2.19 |
|
|
|
|
|
|
|
fL |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: Precoordination of the component with Property: mean volume; the decision was to post coordinate and separate component and property; |
0 |
| 47284-5 |
Platelets |
NCnc |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Platelets [#/volume] in Cord blood |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
47284-5 |
|
|
|
|
Both |
|
|
|
0 |
Platelet # BldCo |
|
|
|
N |
|
#; ABS; absolute; absolutes; Blood - (umbilical) cord; Cnt; Cord (umbilical) blood; Cord bld; Cord blood; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes |
2.7 |
2.19 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
| 47285-2 |
Heparin cofactor II Ag |
ACnc |
PPP |
Pt |
Qn |
|
|
ACTIVE |
Heparin cofactor II Ag [Units/volume] in Platelet poor plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
COAG |
|
47285-2 |
|
|
|
|
Both |
|
|
|
0 |
Heparin CF II Ag PPP-aCnc |
|
|
|
N |
|
2; Antigen; Antigens; Arbitrary concentration; COAGULATION; Cofact; Dermatan sulphate cofactor; HC; HCII; Hematology; Heme; Hep; Hepar; Heparin CF II; Heparn; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombin inhibitor II |
2.7 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 47286-0 |
Differential panel |
- |
Bone mar |
Pt |
Qn |
|
|
ACTIVE |
Differential panel - Bone marrow |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
47286-0 |
|
|
|
|
Order |
|
|
|
0 |
Diff Pnl Mar |
|
|
|
N |
|
BM; BON; Bone marrow; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.67 |
2.19 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 47287-8 |
Hemogram WO platelets panel |
- |
BldCo |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Hemogram without Platelets panel in Cord blood |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
47287-8 |
|
|
|
|
Order |
|
|
|
0 |
Deprecated CBC WO Platelets BldCo |
|
|
|
N |
|
Blood - (umbilical) cord; CBC WO Platelets; Complete Blood Count; Cord (umbilical) blood; Cord bld; Cord blood; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Platelet; Platelets Pnl; Platelt; Plt; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes |
2.36 |
2.19 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 47288-6 |
Complete blood count WO Differential panel |
- |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
CBC WO Differential panel - Cord blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
47288-6 |
|
|
|
|
Order |
|
|
|
0 |
CBC WO diff BldCo |
|
|
|
N |
|
Blood - (umbilical) cord; CBC WO diff; Cord (umbilical) blood; Cord bld; Cord blood; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
2.19 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.68: COMPONENT: Spelled out "Complete blood count" in Formal name based on the LOINC model and for consistency across terms. |
0 |
| 47289-4 |
IgG & IgG subclass panel |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
IgG and IgG subclass panel [Mass/volume] - Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
47289-4 |
|
|
|
|
Order |
|
|
|
0 |
IgG+IgG subclass Pnl Ser-mCnc |
|
|
|
N |
|
Chemistry; IgG subclass Pnl; IgG+IgG subclass Pnl; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses; UniversalLabOrders |
2.73 |
2.19 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
